secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001104659-22-071891
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx shareholders elect all nine director nominees, ratify Deloitte, approve say-on-pay
--------------------------------------------------------------------------------

- 50,160,111 shares present (57.88% of outstanding) at June 15, 2022 annual meeting.
- All nine director nominees elected; votes for ranged from 21,179,908 to 25,579,083.
- Ratification of Deloitte as auditor: 49,488,639 for, 598,786 against.
- Advisory vote on executive compensation approved: 24,778,473 for, 1,082,703 against.
- Broker non-votes were 24,280,981 on director elections and say-on-pay.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465922071891/0001104659-22-071891-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465922071891/tm2218608d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-071891

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer